HERBICIDAL COMBINATION COMPRISING SAFLUFENACIL AND GLUFOSINATE

Abstract

The present invention relates to a herbicidal combination which comprises: a) a herbicide A which is 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl-(1-methylethyl)-amino]sulfonyl]benzamide, b) a herbicide B which is glufosinate or one of its salts, and c) at least one herbicide C different from herbicides A and B which is selected from C.1) herbicides of the group of acetolactate synthase inhibitors which are selected from the group of triazolopyrimidine herbicides, sulfonylamino-carbonyl-triazolinone herbicides and pyrimidinyl(thio) benzoate herbicides, C.2) herbicides of the group of protoporphyrinogen oxidase inhibitors, C.3) herbicides of the group of synthetic auxins, C.4) herbicides of the group of microtubule inhibitors, C.5) herbicides of the group of acetyl-CoA carboxylase inhibitors, C.6) herbicides of the group of photosystem II inhibitors, C.7) herbicides of the group of pigment synthesis inhibitors, and C.8) herbicides of the group of VLCFA inhibitors which are selected from the group of oxyacetamide herbicides and chloroacetamide herbicides.

Claims

1.-15. (canceled)

16. A herbicidal combination comprising a) a herbicide A which is 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl-(1-methylethyl)-amino]sulfonyl]benzamide, b) a herbicide B which is glufosinate or one of its salts, and c) at least one herbicide C different from herbicides A and B which is selected from C.1) herbicides of the group of acetolactate synthase inhibitors which are selected from the group of triazolopyrimidine herbicides, sulfonylamino-carbonyl-triazolinone herbicides and pyrimidinyl(thio) benzoate herbicides, C.2) herbicides of the group of protoporphyrinogen oxidase inhibitors, C.3) herbicides of the group of synthetic auxins, C.4) herbicides of the group of microtubule inhibitors, C.5) herbicides of the group of acetyl-CoA carboxylase inhibitors, C.6) herbicides of the group of photosystem II inhibitors, C.7) herbicides of the group of pigment synthesis inhibitors, and C.8) herbicides of the group of VLCFA inhibitors which are selected from the group of oxyacetamide herbicides and chloroacetamide herbicides.

17. The herbicidal combination as claimed in claim 16, wherein the at least one herbicide C comprises at least one acetolactate synthase inhibitor C.1, selected from the group of diclosulam, cloransulam, flumetsulam, thiencarbazone and their agriculturally acceptable salts and esters.

18. The herbicidal combination as claimed in claim 16, wherein the at least one herbicide C comprises at least one protoporphyrinogen oxidase inhibitor C.2 selected from the group of flumioxazin, butafenacil, carfentrazone, sulfentrazone, acifluorfen, fomesafen, lactofen, oxyfluorfen and their agriculturally acceptable salts and esters.

19. The herbicidal combination as claimed in claim 16, wherein the at least one herbicide C comprises at least one synthetic auxin herbicide C.3 selected from the group of dicamba, quinclorac, fluroxypyr, 2,4-D and their agriculturally acceptable salts and esters.

20. The herbicidal combination as claimed in claim 16, wherein the at least one herbicide C comprises a microtubule inhibitor C.4 which is pendimethalin.

21. The herbicidal combination as claimed in claim 16, wherein the at least one herbicide C comprises at least one acetyl-CoA carboxylase (ACC) inhibitor C.5 selected from the group of fenoxaprop, haloxyfop, clethodim, sethoxydim, profoxydim and their agriculturally acceptable enantiomers, salts and esters.

22. The herbicidal combination as claimed in claim 16, wherein the at least one herbicide C comprises at least one photosystem II inhibitor C.6 selected from the group of atrazine, metribuzin, bentazone and their agriculturally acceptable salts.

23. The herbicidal combination as claimed in claim 16, wherein the at least one herbicide C comprises at least one pigment synthesis inhibitor C.7 selected from the group of benzobicyclon, benzofenap, bicyclopyrone, clomazone, isoxaflutole, mesotrione, pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, topramezone and their agriculturally acceptable salts.

24. The herbicidal combination as claimed in claim 16, wherein the at least one herbicide C comprises at least one VLCFA inhibitor C.8 selected from the group of dimethenamid, acetochlor, metolachlor, metazachlor, flufenacet and their agriculturally acceptable enantiomers.

25. The herbicidal combination as claimed in claim 16, wherein the herbicide B is glufosinate ammonium.

26. The herbicidal combination as claimed in claim 16, wherein the herbicide C is selected from the group of sulfentrazone, flumioxazin, dimethenamid, acetochlor, metolachlor, pendimethalin, dicamba, quinclorac, fluroxypyr, atrazine, benzobicyclon, benzofenap, mesotrione, pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, topramezone, diclosulam, isoxaflutole, bicyclopyrone, 2,4-D and their agriculturally acceptable enantiomers, salts and esters.

27. The herbicidal combination as claimed in claim 16 comprising at least one further herbicide D different from herbicides B and C which is selected from chloroacetamide herbicides, photosystem II inhibitors, pigment synthesis inhibitors, ACC inhibitors, dinitroaniline herbicides and synthetic auxins.

28. The herbicidal combination as claimed in claim 16 further comprising a safener which is preferably selected from the group consisting of benoxacor, cloquintocet, cyprosulfamide, dichlormid, fenclorim, fenchlorazole, furilazole, isoxadifen, mefenpyr, naphthalic acid anhydride, 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane and 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine.

29. A method for controlling undesirable vegetation, which method comprises applying a herbicidal combination according to claim 16 to a locus where undesirable vegetation is present or is expected to be present.

30. A method for burn-down treatment of undesirable vegetation in crops, comprising applying a herbicidal combination according to claim 16 to a locus where crops will be planted before planting or emergence of the crop.

31. The method of claim 29, wherein the at least one herbicide C comprises at least one acetolactate synthase inhibitor C.1, selected from the group of diclosulam, cloransulam, flumetsulam, thiencarbazone and their agriculturally acceptable salts and esters.

32. The method of claim 29, wherein the at least one herbicide C comprises at least one protoporphyrinogen oxidase inhibitor C.2 selected from the group of flumioxazin, butafenacil, carfentrazone, sulfentrazone, acifluorfen, fomesafen, lactofen, oxyfluorfen and their agriculturally acceptable salts and esters.

33. The method of claim 29, wherein the at least one herbicide C comprises at least one synthetic auxin herbicide C.3 selected from the group of dicamba, quinclorac, fluroxypyr, 2,4-D and their agriculturally acceptable salts and esters.

34. The method of claim 29, wherein the at least one herbicide C comprises a microtubule inhibitor C.4 which is pendimethalin.

35. The method of claim 29, wherein the at least one herbicide C comprises at least one acetyl-CoA carboxylase (ACC) inhibitor C.5 selected from the group of fenoxaprop, haloxyfop, clethodim, sethoxydim, profoxydim and their agriculturally acceptable enantiomers, salts and esters.

36. The method of claim 29, wherein the at least one herbicide C comprises at least one photosystem II inhibitor C.6 selected from the group of atrazine, metribuzin, bentazone and their agriculturally acceptable salts.

37. The method of claim 29, wherein the at least one herbicide C comprises at least one pigment synthesis inhibitor C.7 selected from the group of benzobicyclon, benzofenap, bicyclopyrone, clomazone, isoxaflutole, mesotrione, pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, topramezone and their agriculturally acceptable salts.

38. The method of claim 29, wherein the at least one herbicide C comprises at least one VLCFA inhibitor C.8 selected from the group of dimethenamid, acetochlor, metolachlor, metazachlor, flufenacet and their agriculturally acceptable enantiomers.

39. The method of claim 29, wherein the herbicide B is glufosinate ammonium.

40. The method of claim 29, wherein the herbicide C is selected from the group of sulfentrazone, flumioxazin, dimethenamid, acetochlor, metolachlor, pendimethalin, dicamba, quinclorac, fluroxypyr, atrazine, benzobicyclon, benzofenap, mesotrione, pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, topramezone, diclosulam, isoxaflutole, bicyclopyrone, 2,4-D and their agriculturally acceptable enantiomers, salts and esters.

Description

USE EXAMPLES

[0265] The effect of the herbicidal combinations according to the invention of herbicides A, B and C and, if appropriate, safener on the growth of undesirable plants compared to the herbicidally active compounds alone or binary mixtures thereof was demonstrated by the following greenhouse experiments:

[0266] The test plants were first grown to a height of 3 to 20 cm, depending on the plant habit, and only then treated (post-emergence treatment). Here, the herbicidal combinations were suspended, emulsified or dissolved in water as distribution medium and afterwards applied by spraying, using finely distributing nozzles.

[0267] The herbicides A, B and C were used as commercially available formulations and introduced to the spray liquor with the amount of solvent system used for applying the active compound. In the examples, the solvent used was water.

[0268] Saflufenacil was used as a commercially available suspension concentrate having an active ingredient concentration of 340 g/l.

[0269] Glufonsinate was used as a commercially available suspension concentrate containing 280 g/l of glufosinate in the form of its ammonium salt.

[0270] Sulfentrazone was used as a commercially available suspension concentrate having an active ingredient concentration of 480 g/l.

[0271] Flumioxazin was used as a commercially available WG-formulation having an active ingredient concentration of 50% by weight.

[0272] Dimethenamid-P was used as a commercially available emulsifiable concentrate having an active ingredient concentration of 720 g/l.

[0273] Acetochlor was used as a commercially available emulsifiable concentrate having an active ingredient concentration of 840 g/l.

[0274] Pendimethalin was used as a commercially available aqueous capsule suspension having an active ingredient concentration of 455 g/l.

[0275] Dicamba was used as a commercially available SL-formulation having an active ingredient concentration of 480 g/l.

[0276] Atrazin was used as a commercially available WG-formulation having an active ingredient concentration of 84% by weight.

[0277] Mesotrione was used as a commercially available suspension concentrate having an active ingredient concentration of 480 g/l.

[0278] Diclosulam was used as a commercially available WG-formulation having an active ingredient concentration of 84% by weight.

[0279] Isoxaflutole was used as a commercially available suspension concentrate having an active ingredient concentration of 240 g/l.

[0280] 2,4-D was used as a commercially available emulsifiable concentrate containing 660 g/l of 2,4,D in the form of its low volatile ester (which corresponds to its 2-ethylhexylester).

[0281] Tembotrione was used as a commercially available oily suspension concentrate having an active ingredient concentration of 44 g/l.

[0282] S-Metolachlor was used as a commercially available emulsifiable concentrate having an active ingredient concentration of 960 g/l.

[0283] Bicyclopyrone was used in the form of an emulsifiable concentrate having an active ingredient concentration of 50 g/l.

[0284] Topramezone was used as a commercially available suspension concentrate having an active ingredient concentration of 336 g/l.

[0285] Sulcotrione was used as a commercially available suspension concentrate having an active ingredient concentration of 300 g/l.

[0286] Pyrasulfotole was used in the form of an emulsifiable concentrate having an active ingredient concentration of 50 g/l.

[0287] Quinclorac was used as a commercially available suspension concentrate having an active ingredient concentration of 250 g/l.

[0288] Benzobicyclon was used in the form of an emulsifiable concentrate having an active ingredient concentration of 50 g/l.

[0289] Pyrazolynate was used in the form of an emulsifiable concentrate having an active ingredient concentration of 50 g/l.

[0290] Fluroxypyr was used as a commercially available emulsifiable concentrate having an active ingredient concentration of 180 g/l.

[0291] The test period extended over 20 days. During this time, the plants were tended, and their response to the treatments with active compounds was evaluated.

[0292] The evaluation for the damage caused by the chemical compositions was carried out using a scale from 0 to 100%, compared to the untreated control plants. Here, 0 means no damage and 100 means complete destruction of the plants.

[0293] The plants used in the greenhouse experiments belonged to the following species:

TABLE-US-00002 Scientific Name Code Common Name Abutilon theophrasti ABUTH velvetleaf Amaranthus retroflexus AMARE pig weed Avena fatua AVEFA common wild oat Brachiaria decumbens BRADC Surinam grass Brachiaria platyphylla BRAPP broadleaf signalgrass Digitaria sanguinalis DIGSA large crabgrass Echinochloa crus-galli ECHCG barnyard grass Setaria viridis SETVI green foxtail Solanum nigrum SOLNI black nightshade

[0294] Colby's formula was applied to determine whether the composition showed synergistic action. The value E, which is to be expected if the activity of the individual compounds is just additive, was calculated using the method of S. R. Colby (1967) “Calculating synergistic and antagonistic responses of herbicide combinations”, Weeds 15, p. 22 ff. For two component mixtures the value E was calculated by the following formula

E=X+Y−(X.Math.Y/100)

where [0295] X=effect in percent using a mixture of herbicides A and B at application rates a and b, respectively; [0296] Y=effect in percent using herbicide C at an application rate c; [0297] E=expected effect (in %) of A+B+C at application rates a+b+c.

[0298] If the value observed in this manner is higher than the value E calculated according to Colby, a synergistic effect is present.

[0299] Tables 1 to 21 relate to the herbicidal activities of the binary mixture of herbicides A and B, of herbicide C individually and of their combinations in post-emergence application assessed 20 days after treatment (20 DAT).

TABLE-US-00003 TABLE 1 Application in Post-Emergence of Saflufenacil, Glufosinate and Sulfentrazone binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + salfentrazone glufosinate (B) salfentrazone (C) Synergism A B % activity % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.5 6.25 35 1.5 40 0.5 + 6.25 + 1.5 80 61 Y SETVI 0.25 0.25 10 1.5 30 0.25 + 0.25 + 1.5 60 37 Y

TABLE-US-00004 TABLE 2 Application in Post-Emergence of Saflufenacil, Glufosinate and Flumioxazin binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + flumioxazin glufosinate (B) flumioxazin (C) observed expected Synergism A B % activity % activity % activity % activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.25 6.25 15 0.125 80 0.25 + 6.25 + 0.125 90 83 Y SETVI 0.25 0.25 10 0.25 60 0.25 + 0.25 + 0.25 70 64 Y

TABLE-US-00005 TABLE 3 Application in Post-Emergence of Saflufenacil, Glufosinate and Dimethenamid-P binary A + B and solo C applications combination saflufenacil + saflufenacil (A) + glufosinate + dimethenamid-P glufosinate (B) dimethenamid-P (C) Synergism A B % activity % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SOLNI 0.25 6.25 80 18.75 10 0.25 + 6.25 + 18.75 100 82 Y

TABLE-US-00006 TABLE 4 Application in Post-Emergence of Saflufenacil, Glufosinate and Acetochlor binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + acetochlor glufosinate (B) acetochlor (C) observed expected Synergism A B % activity % activity % activity % activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.25 6.25 15 12.5 10 0.25 + 6.25 + 12.5 65 24 Y

TABLE-US-00007 TABLE 5 Application in Post-Emergence of Saflufenacil, Glufosinate and Pendimethalin binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + pendimethalin glufosinate (B) pendimethalin (C) observed expected Synergism A B % activity % activity % activity % activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT AMARE 0.25 6.25 70 75.0 55 0.25 + 6.25 + 75.0 100 87 Y SETVI 0.25 0.25 10 150.0 25 0.25 + 0.25 + 150.0 50 33 Y

TABLE-US-00008 TABLE 6 Application in Post-Emergence of Saflufenacil, Glufosinate and Dicamba binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + dicamba glufosinate (B) dicamba (C) observed expected Synergism A B % activity % activity % activity % activity Y/N weed g ai/ha g ai/ha 20 DAT g ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ABUTH 0.25 0.25 0 17.5 70 0.25 + 0.25 + 17.5 85 70 Y SETVI 0.25 0.25 10 8.75 15 0.25 + 0.25 + 8.75 40 24 Y

TABLE-US-00009 TABLE 7 Application in Post-Emergence of Saflufenacil, Glufosinate and Atrazin binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + atrazin glufosinate (B) atrazin (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SOLNI 0.25 6.25 80 6.25 35 0.25 + 6.25 + 6.25 90 87 Y

TABLE-US-00010 TABLE 8 Application in Post-Emergence of Saflufenacil, Glufosinate and Mesotrione binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + mesotrione glufosinate (B) mesotrione (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.25 0.25 10 2.5 25 0.25 + 0.25 + 2.5 35 33 Y SOLNI 0.25 6.25 80 1.25 85 0.25 + 6.25 + 1.25 100 97 Y

TABLE-US-00011 TABLE 9 Application in Post-Emergence of Saflufenacil, Glufosinate and Diclosulam binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + diclosulam glufosinate (B) diclosulam (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.25 0.25 10 0.5 35 0.25 + 0.25 + 0.5 65 42 Y SOLNI 0.25 6.25 80 0.25 25 0.25 + 6.25 + 0.25 100 85 Y

TABLE-US-00012 TABLE 10 Application in Post-Emergence of Saflufenacil, Glufosinate and Isoxaflutole binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + isoxaflutole glufosinate (B) isoxaflutole (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT AMARE 0.125 6.25 30 0.5 55 0.125 + 6.25 + 0.5 85 69 Y BRAPP 0.25 12.5 5 1.0 25 0.25 + 12.5 + 1.0 50 29 Y

TABLE-US-00013 TABLE 11 Application in Post-Emergence of Saflufenacil, Glufosinate and 2,4-D LV ester binary A + B and solo C applications saflufenacil (A) + 2,4-D LV combination saflufenacil + glufosinate + 2,4-D LV ester glufosinate (B) ester (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT AMARE 0.125 6.25 30 6.25 45 0.125 + 6.25 + 6.25 75 62 Y BRAPP 0.25 12.5 5 6.25 10 0.25 + 12.5 + 6.25 30 15 Y

TABLE-US-00014 TABLE 12 Application in Post-Emergence of Saflufenacil, Glufosinate and Tembotrione binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + tembotrione glufosinate (B) tembotrione (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.25 6.0 10 1.0 0 0.25 + 6.0 + 1.0 25 10 Y AVEFA 0.5 6.0 25 1.0 10 0.5 + 6.0 + 1.0 40 33 Y AMARE 0.25 6.0 90 0.5 80 0.25 + 6.0 + 0.5 100 98 Y ABUTH 0.5 6.0 10 1.0 10 0.5 + 6.0 + 1.0 30 19 Y

TABLE-US-00015 TABLE 13 Application in Post-Emergence of Saflufenacil, Glufosinate and S-Metolachlor binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + S-metolachlor glufosinate (B) S-metolachlor (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.5 6.0 60 300.0 60 0.5 + 6.0 + 300.0 95 84 Y DIGSA 0.5 6.0 15 150.0 0 0.5 + 6.0 + 150.0 60 15 Y BRADC 0.5 6.0 30 150.0 0 0.5 + 6.0 + 150.0 75 30 Y ABUTH 0.5 6.0 10 150.0 10 0.5 + 6.0 + 150.0 65 19 Y

TABLE-US-00016 TABLE 14 Application in Post-Emergence of Saflufenacil, Glufosinate and Bicyclopyrone binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + bicyclopyrone glufosinate (B) bicyclopyrone (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT SETVI 0.25 6.0 15 1.0 0 0.25 + 6.0 + 1.0 35 15 Y ECHCG 0.5 6.0 10 20.0 75 0.5 + 6.0 + 20.0 90 78 Y AVEFA 0.5 6.0 10 2.0 0 0.5 + 6.0 + 2.0 20 10 Y

TABLE-US-00017 TABLE 15 Application in Post-Emergence of Saflufenacil, Glufosinate and Topramezone binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + topramezone glufosinate (B) topramezone (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ECHCG 0.5 6.0 10 0.25 20 0.5 + 6.0 + 0.25 55 28 Y DIGSA 0.5 6.0 15 0.25 10 0.5 + 6.0 + 0.25 40 24 Y AVEFA 0.5 6.0 25 0.25 10 0.5 + 6.0 + 0.25 45 33 Y ABUTH 0.5 6.0 10 0.25 0 0.5 + 6.0 + 0.25 40 10 Y

TABLE-US-00018 TABLE 16 Application in Post-Emergence of Saflufenacil, Glufosinate and Sulcotrione binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + sulcotrione glufosinate (B) sulcotrione (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ECHCG 0.5 6.0 10 2.5 30 0.5 + 6.0 + 2.5 40 37 Y BRADC 0.25 6.0 0 5.0 0 0.25 + 6.0 + 5.0 10 0 Y ABUTH 0.5 6.0 10 5.0 85 0.5 + 6.0 + 5.0 90 87 Y

TABLE-US-00019 TABLE 17 Application in Post-Emergence of Saflufenacil, Glufosinate and Pyrasulfotole binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + pyrasulfotole glufosinate (B) pyrasulfotole (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ECHCG 0.5 6.0 10 2.5 80 0.5 + 6.0 + 2.5 90 82 Y DIGSA 0.5 6.0 15 5.0 35 0.5 + 6.0 + 5.0 55 45 Y BRADC 0.25 6.0 0 5.0 0 0.25 + 6.0 + 5.0 15 0 Y

TABLE-US-00020 TABLE 18 Application in Post-Emergence of Saflufenacil, Glufosinate and Quinclorac binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + quinclorac glufosinate (B) quinclorac (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT ECHCG 0.5 6.0 30 5.0 0 0.5 + 6.0 + 5.0 35 30 Y AVEFA 0.25 6.0 5 5.0 0 0.25 + 6.0 + 5.0 10 5 Y

TABLE-US-00021 TABLE 19 Application in Post-Emergence of Saflufenacil, Glufosinate and Benzobicyclon binary A + B and solo C applications saflufenacil (A) + benzobicyclon combination saflufenacil + glufosinate + benzobicyclon glufosinate (B) (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT DIGSA 0.5 6.0 15 20.0 60 0.5 + 6.0 + 20.0 75 66 Y AVEFA 0.5 6.0 25 10.0 10 0.5 + 6.0 + 10.0 40 33 Y AMARE 0.25 6.0 90 20.0 60 0.25 + 6.0 + 20.0 100 96 Y ABUTH 0.5 6.0 10 20.0 90 0.5 + 6.0 + 20.0 95 91 Y

TABLE-US-00022 TABLE 20 Application in Post-Emergence of Saflufenacil, Glufosinate and Pyrazolynate binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + pyrazolynate glufosinate (B) pyrazolynate (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT DIGSA 0.5 6.0 15 10.0 0 0.5 + 6.0 + 10.0 20 15 Y BRADC 0.25 6.0 0 10.0 0 0.25 + 6.0 + 10.0 10 0 Y ABUTH 0.5 6.0 10 20.0 25 0.5 + 6.0 + 20.0 55 33 Y

TABLE-US-00023 TABLE 21 Application in Post-Emergence of Saflufenacil, Glufosinate and Fluroxypyr binary A + B and solo C applications saflufenacil (A) + combination saflufenacil + glufosinate + fluroxypyr glufosinate (B) fluroxypyr (C) Synergism A B % activity g % activity observed % activity expected % activity Y/N weed g ai/ha g ai/ha 20 DAT ai/ha 20 DAT g ai/ha 20 DAT 20 DAT 20 DAT AVEFA 0.25 6.0 5 10.0 0 0.25 + 6.0 + 10.0 10 5 Y ABUTH 0.5 6.0 35 20.0 50 0.5 + 6.0 + 20.0 70 68 Y